BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25887489)

  • 21. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C; Ni W; Cai X; Cui J
    Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
    Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
    J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
    Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
    J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
    Church D; Lloyd T; Peirano G; Pitout J
    Scand J Infect Dis; 2013 Apr; 45(4):265-70. PubMed ID: 23113657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.
    Wang WS; Liu CP; Lee CM; Huang FY
    J Microbiol Immunol Infect; 2004 Dec; 37(6):359-65. PubMed ID: 15599468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
    Bilen NM; Sahbudak Bal Z; Güner Özenen G; Yildirim Arslan S; Ozek G; Ozdemir Karadas N; Yazici P; Cilli F; Kurugöl Z
    Pediatr Infect Dis J; 2023 May; 42(5):374-380. PubMed ID: 36795557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
    Lee YL; Liu CE; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
    Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
    J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH; Yu CM; Hsu ST; Wu RX
    J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
    Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M
    J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
    Mori M; Tsunemine H; Imada K; Ito K; Kodaka T; Takahashi T
    Ann Hematol; 2014 Jun; 93(6):901-11. PubMed ID: 24535696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
    Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
    Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
    Hevia EC; Wooten L; Carr AL
    Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
    Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
    Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First report of survival in two patients with hematologic malignancy and Stenotrophomonas maltophilia hemorrhagic pneumonia treated with trimethoprim-sulfamethoxazole-based combination antibiotic therapy.
    Penagos SC; Giraldo N; Vallejo C; McEwen O; Hidron A
    J Infect Chemother; 2020 Apr; 26(4):397-399. PubMed ID: 31882384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron.
    Hu LF; Chang X; Ye Y; Wang ZX; Shao YB; Shi W; Li X; Li JB
    Int J Antimicrob Agents; 2011 Mar; 37(3):230-4. PubMed ID: 21296557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.